Ctxr stock forecast 2025
The Wall Street analyst predicted that Citius Pharmaceuticals 's share price could reach $4.00 by Aug 10, 2024. The average Citius Pharmaceuticals stock price prediction forecasts a potential upside of 495.24% from the current CTXR share price of $0.67.The put/call ratio of CTXR is 0.03, indicating a bullish outlook. Analyst Price Forecast Suggests 314.64% Upside As of April 7, 2023, the average one-year price target for Citius Pharmaceuticals ...
Did you know?
CTXR support price is $.64 and resistance is $.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTXR stock will trade within this expected range on the day. View a ...Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing.Based on 1 Wall Street analysts offering 12 month price targets for Vintage Wine Estates in the last 3 months. The average price target is $1.10 with a high forecast of $1.10 and a low forecast of $1.10. The average price target represents a 93.32% change from the last price of $0.57. Highest Price Target $1.10. Average Price Target $1.10.Open Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Citius Pharmaceuticals Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.Coupang stock forecast for 07.10.2023. Estimated Average Forecasted Coupang Price: 17.46 Negative intraday dynamics of the instrument is expected with 6.018% volatility is expected. Pessimistic forecast: 16.85 Optimistic: 17.93 Coupang stock forecast for 08.10.2023.Wall Street is still looking for Teladoc Health's stock to double to $180 per share in the next year, and revenue is expected to jump from $1.1 billion in 2020 to $5 billion for a 35% CAGR. So an ...Find real-time SPIR - Spire Global Inc stock quotes, company profile, news and forecasts from CNN Business.In 2019, the global gaming market was worth roughly $151.55 billion. It's expected to be worth $256.97 billion by 2025 - an annual growth rate of 9.17% from 2020 to 2025. Most recent data shows ...CTXR : Citius Pharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical AnalysisMino-Lok® contains a proprietary combination of minocycline, edetate (disodium EDTA), and ethyl alcohol, all of which act synergistically to break down bacterial biofilms, eradicate the bacteria, provide anti-clotting properties to maintain patency in CVCs, and salvage the indwelling catheter. Mino-Lok® is used in two-hour locking cycles ...Corus Entertainment Stock Predictions 2025 Stock Forecast for the Price of an Corus Entertainment Share in Jan 2025. In January 2025, analysts believe the stock price will be C$4.94. An increase of 425.08% compared to the previous month's estimate.Last Five Real-Time Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly ...Find the latest Citius Pharmaceuticals, Inc. CTXR analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. CTXR ... The site suggested that the stock could be a few cents shy of $4.7 in 2024, almost reach $6.5 by 2025, and be closing in on $8.2 a year later. A five year forecast for the stock, meanwhile, suggested it could be touching $9.96 by 2027. This would represent a 750% potential upside from today's $1.17 level.The 12-month price forecast for Rivian stock as of August 2023 is $28.32. That figure represents the consensus of 19 Wall Street analysts. However, the highest analyst prediction estimates Rivian stock could be as high as $44 12 months from now. The most bearish analyst has a 12-month price target of just $12 per share.The yield on the 10-Year Treasury moved up sharply as the January BLS Jobs report showed 517,000 jobs were created in the first month of 2023 and the unemployment rate fell to 3. Get the latest ...See Citius Pharmaceuticals, Inc. (CTXR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Sep 11, 2023 · American Battery Technology's stock was trading at $0.4069 at the beginning of the year. Since then, ABML stock has increased by 2,315.8% and is now trading at $9.83. View the best growth stocks for 2023 here. CTXR Stock Forecast, Price Targets and Analysts Predictions Based on 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. The average price target is $7.00 with a high ...
People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Comcast Corp Stock Forecast 2023. In the last five quarters, Comcast Corp's Price Target has fallen from $75.01 to $49.77 - a -33.65% decrease. Eighteen analysts predict that Comcast Corp's share price will fall in the coming year, reaching $43.00. This would represent a decrease of -13.6%.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Oncolytics Biotech share forecasts, stock quote and buy / sell signals below. According to present data Oncolytics Biotech's ONCY shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Citius Pharmaceuticals, Inc. ( NASDAQ:CTXR ) is possibly approaching a major achievement in its business, so we would... Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing.Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a Cranford, New Jersey based late-stage drug concern focused on the development of therapies that are typically reformulations of previously approved ...
About the Citius Pharmaceuticals, Inc. stock forecast. As of 2023 September 28, Thursday current price of CTXR stock is 0.692$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Citius Pharmaceuticals stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period.Dividends. Citius Pharmaceuticals Inc. advanced stock charts by MarketWatch. View CTXR historial stock data and compare to other stocks and exchanges.Find real-time SPIR - Spire Global Inc stock quotes, company profile, news and forecasts from CNN Business.…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Track Citius Pharmaceuticals Inc (CTXR) Stock Price,. Possible cause: Navidea Biopharmaceuticals Inc () Stock Market info Recommendations: Buy or sell Navidea.
If you're new to stock investing, here's how to buy Bit Digital stock. What is BTBT's Price Target? According to 1 Wall Street analyst that have issued a 1 year BTBT price target, the average BTBT price target is $4.00 , with the highest BTBT stock price forecast at $4.00 and the lowest BTBT stock price forecast at $4.00 . Their CTXR share price forecasts range from $4.00 to $4.00. On average, they expect the company's share price to reach $4.00 in the next year. This suggests a possible upside of 465.1% from the stock's current price. View analysts price targets for CTXR or view top-rated stocks among Wall Street analysts.
Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 8.00 and a low estimate of 4.00. The ...Based on 19 Wall Street analysts offering 12 month price targets for Sunrun in the last 3 months. The average price target is $32.00 with a high forecast of $60.00 and a low forecast of $12.00. The average price target represents a 168.23% change from the last price of $11.93. Highest Price Target $60.00. Average Price Target $32.00.
Sunrun Stock forecast & analyst price target predict Gevo Stock Forecast, GEVO stock price prediction. Price target in 14 days: 1.059 USD. The best long-term & short-term Gevo share price prognosis for 2023, 2024, 2025 ... Forecast Price target 5.330.000.00% The 3 analysts offering 1 year pBelow you can see the results of forecasts A high-level overview of Archer Aviation Inc. (ACHR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Stock Price Forecast. The 8 analysts offering 12-month price forecasts for OrganiGram Holdings Inc have a median target of 3.04, with a high estimate of 4.81 and a low estimate of 1.52. The median ... For Quantum Computing stock forecast for 2023, 4 brokerages have issued 1 year price objectives for Catalyst Pharmaceuticals' stock. Their CPRX share price forecasts range from $24.00 to $27.00. On average, they expect the company's share price to reach $24.75 in the next twelve months. This suggests a possible upside of 97.5% from the stock's current price.Based on short-term price targets offered by three analysts, the average price target for Citius Pharmaceuticals, Inc. comes to $5.33. The forecasts range from a low of $4.00 to a high of $8.00 ... Inmode Ltd () Stock Market info RecommendaModerna Inc () Stock Market info Recommendations: Buy oThe projected low price target is $64.00 while Entering text into the input field will update the search result below Investors in Citius Pharmaceuticals, Inc. CTXR need to pa CRMD Stock 12 Months Forecast. $14.33. (302.53% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Cormedix in the last 3 months. The average price target is $14.33 with a high forecast of $19.00 and a low forecast of $6.00. The average price target represents a 302.53% change from the last price of $3.56.The 1 analysts offering 12-month price forecasts for RegenETP, Inc have a median target of 0.80, with a high estimate of 0.80 and a low estimate of 0.80. The median estimate represents a +1,130.77 ... 4 equities research analysts have issued twelve-month t[According to our Citius Pharmaceuticals stock predctxr stock forecast 2025 citius pharmaceut Target values for the price of one Texas Instruments share for Feb 2025. The weighted average target price per Texas Instruments share in Feb 2025 is: 165.00. In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 5.179% volatility is expected. Pessimistic target level: 160.39.Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927).